Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2006-08-29
2006-08-29
Witz, Jean C. (Department: 1651)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Reexamination Certificate
active
07097862
ABSTRACT:
The disclosure describes a method of inhibiting TNF in subjects comprising administering a TNF inhibiting amount of an extract ofEleutherococcus senticosus maximto a subject. In addition, the present disclosure provides a method of inhibiting TNF in a cell line comprising administering to the cell line a TNF inhibiting amount of an extract fromEleutherococcus senticosus maxim. Finally, the disclosure provides a method of treating a TNF mediated disorder in a subject, comprising administering an effective amount of an extract ofEleutherococcus senticosus maximto the subject.
REFERENCES:
patent: 3679893 (1972-07-01), Cook et al.
patent: 3992364 (1976-11-01), Kuhlmey
patent: 4684740 (1987-08-01), Higuchi et al.
patent: 5180588 (1993-01-01), Shinmen et al.
patent: 5211953 (1993-05-01), Shinmen et al.
patent: 5215743 (1993-06-01), Singh et al.
patent: 5288852 (1994-02-01), Yamada et al.
patent: 0140134 (1985-05-01), None
patent: 1142571 (1969-02-01), None
patent: 62-167791 (1993-08-01), None
Brown, Health Store News, Oct./Nov. 1991.
Brown, Townsend Letter for Doctors, Jul. 1991, pp. 597-598.
PCM-4 Package Label, Omega.
“The Merck Manual of Diagnosis and Therapy” Merck Research Laboratories, Rahway, NJ Sixteenth Edition, 1992.
Hirano, et al. “Suppression of mitogen-induced proliferation of human peripheral blood lymphocytes by plant lignans”, Planta Med 57(4): 331-4, 1991.
Oshima, et al., “Anticomplementary Activity of the Constituents of Eucommia Ulmoides Bark”, J.Ethnopharmacology 23:159-164, 1988.
Wagner, et al, “Studies on the Standardization of Mistletoe Preparations”, Oncology 43: Suppl 1:16-22, 1986.
Bohn et al. “Flow-cytometric Studies withEleutherococcus senticosusExtract as an Immunomodulatory Agent” Arzneim-Forsch/Drug Res 37(II) No. 10 1193-1196, 1987.
Donald J. Brown, “Phytotherapy Review & Commentary”, Townsend Letter for Doctors. Aug./Sep. 1991.
Donald J. Brown, “Phytotherapy Review & Commentary”, Townsend Letter for Doctors, Jul. 1991, p. 597.
Lark Lands, Ph.D., “Drug Information for People Living with HIV”, HIV Treatment Strategy, Part III, Jun. 1991.
“The Drug that Builds Russians”, New Scientist, Aug. 21, 1980, pp. 576-579.
Excerpted from “Eleutherococcus: Strategy of the Use and New Fundamental Data”, Barenboim, G.M., Kozlova, N.B.
Weger, “Preparation and Chemistry ofEleutherococcus senticosusMaxim.”, Sep. 20, 19990.
Baier, et al., Improvement of Impaired Mitogen-Induced Interferon-Gamma Release of Peripheral Blood Mononuclear Cells Derived from Tumor Patients by “P”., Abstract from Onkologie: Internationale Zeitschrift fuer Krebsforschung und-Behandlung, 1991; 14; Supplement 2;7.
Autoimmunity and Autoimmune Diseases, p. 821.
Duesberg, AIDS epidemiology: Inconsistencies with . . . virus and with infectious disease:, Proc. Natl. Acad. Sci.—USA, 88:1575-1579 (1991).
Duesberg, et al., “Is the AIDS Virus a Science Fiction?”, Policy Review. pp. 40-51.
Root-Bernstein, “AIDS is More than HIV: Part I”, Genetic Engineering News, Sep. 1, 1992, pp. 4-6.
“PCM-4 product label.”
Andrew Pelter, et al., Synthesis of 2.6 Diaryl-4, 8-dihydroxy-3, 7-dioxabicyclo {3.3.0.} ictaubesim Journal of the Chemical Society, vol. 1:175-181 (Jan. 1982).
Oshima, et al., “Anticomplementary Activity of the Constituents of Eucommia Ulmoides Bark”, Journal of Ethnopharmacology, 23 (1988) pp. 159-164.
Hirano, et al., 115 CA 174084p (1991).
Starosel'skii, et al. (1991) Vopr Onkol, (37) pp. 875-877 (Abstract).
Kamaukh, et al. (1990) Vrach Delo (10), pp. 119-121.
Domashenko, et al., (1989) Lab Delo (5), pp. 15-17.
Chubarev, et al. (1989) Farmakol Toksikol 52, pp. 55-59 (Abstract).
Strel'chuk, (1987) Tsitol Genet, 21 (2) pp. 136-139 (Abstract).
Gubar', et al., (1993) Biotechnology, 3 pp. 28-31 (Abstract).
Molokoviskii, et al., (1989) Probl Endokrinol (Mosk), 35 (6) pp. 82-87.
Medline Abstract accession No.: 93097542.
Medline Abstract accession No.: 86291252.
“PCM-4 package insert”, (1991).
“PCM-4 promotional literature”, (1991).
Van De Graaff, et al., Concepts of Human Anatomy and Pysiology, (1986) Glossary, Wm.C. Brown Publishers, Dubuque, Iowa.
Donald J. Brown, “PCM-4: New Standard of Excellence in Immunomodulation”, Health Store News (Nov. 1992).
Bradley Arant Rose & White LLP
Witz Jean C.
LandOfFree
Methods of inhibiting tumor necrosis factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inhibiting tumor necrosis factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting tumor necrosis factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3625275